Patent ID: 7037909

Claim:
A compound of the formula I: wherein: R 1 is an aryl or heteroaryl group, wherein said aryl or heteroaryl group is unsubstituted or optionally substituted with one or more substituents selected from the group consisting of halogen, —OH, —OR 8 , —COR 8 , —COOR 8 , —CONR 8 R 9 , —NR 8 R 9 , —CN, —NO 2 , —S(O) 2 R 8 , —SO 2 NR 8 R 9 , —CF 3 , lower alkyl, cycloalkyl, heterocycle, alkenyl, alkynyl and aryl; each R 2 and R 3 is independently selected from the group consisting of hydrogen halogen, —OH, —OR 7 , —NR 7 R 8 , —CN, —COR 8 , —COOR 8 , —CONR 8 R 9 , —OF 3 , lower alkyl, cycloalkyl, heterocycle, alkenyl and alkynyl; or R 2 and R 3 , together with the carbon atom to which they are attached can form a cycloalkyl or heterocycle; R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of hydrogen, halogen, —OR 8 , —COR 8 , —COOR 8 , —CONR 8 R 9 , —NR 8 R 9 , —ON, —NO 2 , —S(O) n R 8 (wherein n is 0, 1 or 2), —SO 2 R 7 R 8 , —CF 3 , lower alkyl, cycloalkyl, heterocycle, alkenyl, alkynyl, and aryl; each R 8 and R 9 is independently selected from the group consisting of hydrogen, lower alkyl, cycloalkyl, heterocycle, alkenyl, alkynyl, aryl, aminoalkyl, alkylaminoalkyl, and dialkylaminoalkyl, or R 8 and R 9 together with the atom to which they are attached form a heteroalicyclic ring optionally substituted with a group selected from the group consisting of alkyl, —OH and amino; and p is 1, 2, 3, 4 or 5, it being understood that when p is greater than 1, the R 2 and R 3 groups on each carbon atom may be the same as or different from the R 2 and R 3 groups on any adjacent carbon atom; or a pharmaceutically acceptable salt thereof.